Literature DB >> 24974737

Cisd2 mediates lifespan: is there an interconnection among Ca²⁺ homeostasis, autophagy, and lifespan?

C-H Wang1, C-H Kao, Y-F Chen, Y-H Wei, T-F Tsai.   

Abstract

CISD2, an evolutionarily conserved novel gene, plays a crucial role in lifespan control and human disease. Mutations in human CISD2 cause type 2 Wolfram syndrome, a rare neurodegenerative and metabolic disorder associated with a shortened lifespan. Significantly, the CISD2 gene is located within a region on human chromosome 4q where a genetic component for human longevity has been mapped through a comparative genome analysis of centenarian siblings. We created Cisd2 knockout (loss-of-function) and transgenic (gain-of-function) mice to study the role of Cisd2 in development and pathophysiology, and demonstrated that Cisd2 expression affects lifespan in mammals. In the Cisd2 knockout mice, Cisd2 deficiency shortens lifespan and drives a panel of premature aging phenotypes. Additionally, an age-dependent decrease of Cisd2 expression has been detected during normal aging in mice. Interestingly, in the Cisd2 transgenic mice, we demonstrated that a persistent level of Cisd2 expression over the different stages of life gives the mice a long-lived phenotype that is linked to an extension in healthy lifespan and a delay in age-associated diseases. At the cellular level, Cisd2 deficiency leads to mitochondrial breakdown and dysfunction accompanied by cell death with autophagic features. Recent studies revealed that Cisd2 may function as an autophagy regulator involved in the Bcl-2 mediated regulation of autophagy. Furthermore, Cisd2 regulates Ca(2+) homeostasis and Ca(2+) has been proposed to have an important regulatory role in autophagy. Finally, it remains to be elucidated if and how the regulation in Ca(2+) homeostasis, autophagy and lifespan are interconnected at the molecular, cellular and organism levels.

Entities:  

Keywords:  aging; longevity; mitochondria; mitochondria-associated ER membranes; type 2 Wolfram syndrome

Mesh:

Substances:

Year:  2014        PMID: 24974737     DOI: 10.3109/10715762.2014.936431

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  21 in total

1.  Binding of thiazolidinediones to the endoplasmic reticulum protein nutrient-deprivation autophagy factor-1.

Authors:  Werner J Geldenhuys; Robert Skolik; Mary E Konkle; Michael A Menze; Timothy E Long; Aaron R Robart
Journal:  Bioorg Med Chem Lett       Date:  2019-02-01       Impact factor: 2.823

Review 2.  Mitochondrial remodeling: Rearranging, recycling, and reprogramming.

Authors:  Roberta A Gottlieb; Daniel Bernstein
Journal:  Cell Calcium       Date:  2016-04-20       Impact factor: 6.817

Review 3.  Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders.

Authors:  Sweta Shah; Marc Marie Dooms; Sofia Amaral-Garcia; Mariana Igoillo-Esteve
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

4.  Disrupting CISD2 function in cancer cells primarily impacts mitochondrial labile iron levels and triggers TXNIP expression.

Authors:  Ola Karmi; Yang-Sung Sohn; Sara I Zandalinas; Linda Rowland; Skylar D King; Rachel Nechushtai; Ron Mittler
Journal:  Free Radic Biol Med       Date:  2021-09-20       Impact factor: 7.376

5.  Activation of apoptosis in NAF-1-deficient human epithelial breast cancer cells.

Authors:  Sarah H Holt; Merav Darash-Yahana; Yang Sung Sohn; Luhua Song; Ola Karmi; Sagi Tamir; Dorit Michaeli; Yuting Luo; Mark L Paddock; Patricia A Jennings; José N Onuchic; Rajeev K Azad; Eli Pikarsky; Ioav Z Cabantchik; Rachel Nechushtai; Ron Mittler
Journal:  J Cell Sci       Date:  2015-11-30       Impact factor: 5.285

6.  A donor splice site mutation in CISD2 generates multiple truncated, non-functional isoforms in Wolfram syndrome type 2 patients.

Authors:  Monica Cattaneo; Lucia La Sala; Maurizio Rondinelli; Edoardo Errichiello; Orsetta Zuffardi; Annibale Alessandro Puca; Stefano Genovese; Antonio Ceriello
Journal:  BMC Med Genet       Date:  2017-12-13       Impact factor: 2.103

7.  Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax - a liver transcriptomics approach.

Authors:  Hanno Schmidt; Assaf Malik; Anne Bicker; Gesa Poetzsch; Aaron Avivi; Imad Shams; Thomas Hankeln
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

8.  A novel CISD2 mutation associated with a classical Wolfram syndrome phenotype alters Ca2+ homeostasis and ER-mitochondria interactions.

Authors:  Cécile Rouzier; David Moore; Cécile Delorme; Sandra Lacas-Gervais; Samira Ait-El-Mkadem; Konstantina Fragaki; Florence Burté; Valérie Serre; Sylvie Bannwarth; Annabelle Chaussenot; Martin Catala; Patrick Yu-Wai-Man; Véronique Paquis-Flucklinger
Journal:  Hum Mol Genet       Date:  2017-05-01       Impact factor: 6.150

9.  Comparative proteomic profiling reveals a role for Cisd2 in skeletal muscle aging.

Authors:  Yi-Long Huang; Zhao-Qing Shen; Chia-Yu Wu; Yuan-Chi Teng; Chen-Chung Liao; Cheng-Heng Kao; Liang-Kung Chen; Chao-Hsiung Lin; Ting-Fen Tsai
Journal:  Aging Cell       Date:  2017-11-23       Impact factor: 9.304

10.  CISD2 promotes the proliferation of glioma cells via suppressing beclin‑1‑mediated autophagy and is targeted by microRNA‑449a.

Authors:  Ai-Gang Sun; Fan-Guo Meng; Ming-Guang Wang
Journal:  Mol Med Rep       Date:  2017-09-27       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.